Targeted treatment of chondrosarcoma with a bacteriophage-based particle delivering a secreted tumor necrosis factor-related apoptosis-inducing ligand

Autor: Chongchai, Aitthiphon, Bentayebi, Kaoutar, Chu, Grace, Yan, Wenqing, Waramit, Sajee, Phitak, Thanyaluck, Kongtawelert, Prachya, Pothacharoen, Peraphan, Suwan, Keittisak, Hajitou, Amin

Publikováno v: In Molecular Therapy: Oncology 20 June 2024 32(2)

Next-generation of targeted AAVP vectors for systemic transgene delivery against cancer

Autor: Suwan, Keittisak, Yata, Teerapong, Waramit, Sajee, Przystal, Justyna M., Stoneham, Charlotte A., Bentayebi, Kaoutar, Asavarut, Paladd, Chongchai, Aitthiphon, Pothachareon, Peraphan, Lee, Koon-Yang, Topanurak, Supachai, Smith, Tracey L., Gelovani, Juri G., Sidman, Richard L., Pasqualini, Renata, Arap, Wadih, Hajitou, Amin

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America, 2019 Sep 01. 116(37), 18571-18577.

Externí odkaz: https://www.jstor.org/stable/26851945

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Efficacy of systemic temozolomide‐activated phage‐targeted gene therapy in human glioblastoma

Autor: Przystal, Justyna Magdalena, Waramit, Sajee, Pranjol, Md Zahidul Islam, Yan, Wenqing, Chu, Grace, Chongchai, Aitthiphon, Olaciregui, Nagore Gene, Tabatabai, Ghazaleh, Carcaboso, Angel Montero, Aboagye, Eric Ofori, Suwan, Keittisak, Hajitou, Amin

lioblastoma multiforme (GBM) is the most lethal primary intracranial malignant neoplasm in adults and most resistant to treatment. Integration of gene therapy and chemotherapy, chemovirotherapy, has the potential to improve treatment. We have introdu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::f01f51a47aa428678a9ac14f55cb93b7
http://sro.sussex.ac.uk/id/eprint/90830/1/emmm.201708492.pdf

Efficacy of systemic temozolomide-activated phage-targeted gene therapy in human glioblastoma.

Autor: Przystal JM; Phage Therapy Group, Division of Brain Sciences, Department of Medicine, Imperial College London, London, UK., Waramit S; Phage Therapy Group, Division of Brain Sciences, Department of Medicine, Imperial College London, London, UK., Pranjol MZI; Phage Therapy Group, Division of Brain Sciences, Department of Medicine, Imperial College London, London, UK., Yan W; Phage Therapy Group, Division of Brain Sciences, Department of Medicine, Imperial College London, London, UK., Chu G; Phage Therapy Group, Division of Brain Sciences, Department of Medicine, Imperial College London, London, UK., Chongchai A; Thailand Excellence Centre for Tissue Engineering and Stem Cells, Department of Biochemistry, Faculty of Medicine Chiang Mai University, Chiang Mai, Thailand., Samarth G; Phage Therapy Group, Division of Brain Sciences, Department of Medicine, Imperial College London, London, UK., Olaciregui NG; Institute de Recerca Sant Joan de Deu, Barcelona, Spain.; Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Deu, Barcelona, Spain., Tabatabai G; Interdisciplinary Division of Neuro-Oncology, Hertie Institute for Clinical Brain Research, Center for CNS Tumors, Comprehensive Cancer Center, University Hospital Tübingen, Eberhard Karls University, Tübingen, Germany.; German Cancer Consortium (DKTK), DKFZ Partner Site Tübingen, Tübingen, Germany., Carcaboso AM; Institute de Recerca Sant Joan de Deu, Barcelona, Spain.; Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Deu, Barcelona, Spain., Aboagye EO; Comprehensive Cancer Imaging Centre, Imperial College London, Faculty of Medicine, London, UK., Suwan K; Phage Therapy Group, Division of Brain Sciences, Department of Medicine, Imperial College London, London, UK., Hajitou A; Phage Therapy Group, Division of Brain Sciences, Department of Medicine, Imperial College London, London, UK a.hajitou@imperial.ac.uk.

Publikováno v: EMBO molecular medicine [EMBO Mol Med] 2019 Apr; Vol. 11 (4).